Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China 2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease 2021-10-19 17:52
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick 2021-10-19 15:01
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications 2021-10-18 20:00
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers 2021-10-18 11:05
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform 2021-10-14 23:55
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies 2021-10-13 02:30
NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification 2021-10-12 16:00
ProfoundBio Announces Presentation on Novel, Proprietary Linker-Drug Technology to Enable Antibody-Drug Conjugates (ADCs) with an Expanded Therapeutic Window at the AACR-NCI-EORTC International Conference 2021-10-08 11:39
Amplo Biotechnology Closes Series Seed Financing to Advance Gene Therapies for The Treatment of Neuromuscular Junction Disorders 2021-10-06 23:30
I-Mab Announces Upcoming Participation at October Conferences 2021-10-01 20:00
Binhai sets ambitious biomedical goals with support of key companies 2021-10-01 01:08
Penn mRNA Biology Pioneer Drew Weissman Joins RVAC's Science Advisory Board 2021-10-01 00:50
1 137 138 139 140 141 261